GPNX
NOTIFICATION PROCESSED BY IB
19/09/2022
Voltar para busca
Dado oficial do USPTO
EMSIVEL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
19/09/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
25/10/2021
Data de registro
31/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/05/2022
Última transação
31/05/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
MAJCHER HARTNETT, MEGAN
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaexcluding mineral salts or products containing mineral salts and excluding products for the prevention and treatment or respiratory disorders and diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/08/2022
FIMP
FINAL DISPOSITION PROCESSED
25/08/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
30/06/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/05/2022
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/03/2022
PUBO
PUBLISHED FOR OPPOSITION
15/03/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2022
DOCK
ASSIGNED TO EXAMINER
07/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/01/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/12/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
09/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EMSIVEL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.